BioCentury
ARTICLE | Company News

Express Scripts wants blood disorder gene therapies exclusively

August 17, 2018 6:37 PM UTC

Express Scripts Holding Co. (NASDAQ:ESRX) said it is in discussions with gene therapy companies to become the exclusive distributor for blood disorder treatments, which could enable the PBM to test a payment-over-time reimbursement model.

The PBM said the companies include BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and bluebird bio Inc. (NASDAQ:BLUE). bluebird confirmed to BioCentury that Express Scripts is among groups with which it is discussing payment models; and BioMarin did not respond to inquiries...